Ventyx Biosciences
VTYX
VTYX
120 hedge funds and large institutions have $112M invested in Ventyx Biosciences in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
86% less call options, than puts
Call options by funds: $426K | Put options by funds: $2.95M
94% less capital invested
Capital invested by funds: $1.9B → $112M (-$1.78B)
Holders
120
Holding in Top 10
1
Calls
$426K
Puts
$2.95M
Top Buyers
| 1 | +$8.76M | |
| 2 | +$4.94M | |
| 3 | +$4.63M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.38M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.28M |
Top Sellers
| 1 | -$60.1M | |
| 2 | -$55.5M | |
| 3 | -$46.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$45.1M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$43.7M |